NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

8/12/24 9:15:00 AM ET

Medical/Dental Instruments

Health Care

Get the next $NXGL alert in real time by email

Management will host a conference call at 4:30 P.M. ET on the same day

LANGHORNE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced it will report its financial results for the second quarter 2024, after the market closes on August 14, 2024. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.

Second Quarter 2024 Financial Results Conference Call

Date: August 14, 2024

Time: 4:30 P.M. ET

Live Call: + 1-800-579-2543 (U.S. Toll Free) or + 1-785-424-1789 (International)

Webcast: Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through August 28, 2024 by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11156720. An archived version of the webcast will also be available for 90 days.

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:

Valter Pinto, Managing Director

KCSA Strategic Communications

212.896.1254

[email protected]

Get the next $NXGL alert in real time by email

Date

Price Target

Rating

Analyst

2/25/2022

$6.00

Buy

Maxim Group

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Chat with this insight

Recent Analyst Ratings for
$NXGL

$NXGL
Press Releases

Fastest customizable press release news feed in the world

NEXGEL to Participate in Upcoming October Investor Conferences

NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

$NXGL
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Director Henry Scott Robert

SEC Form 4 filed by Director Zeldis Jerome B

SEC Form 4 filed by Director Glassman Steven Mark

$NXGL
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Stein John Nachum bought $25,000 worth of shares (10,000 units at $2.50), increasing direct ownership by 2% to 471,820 units (SEC Form 4)

Director Glassman Steven Mark bought $25,000 worth of shares (10,000 units at $2.50), increasing direct ownership by 7% to 145,025 units (SEC Form 4)

Director Zeldis Jerome B bought $25,000 worth of shares (10,000 units at $2.50), increasing direct ownership by 11% to 103,028 units (SEC Form 4)

$NXGL
SEC Filings

NexGel Inc filed SEC Form 8-K: Regulation FD Disclosure

NexGel Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form 10-Q filed by NexGel Inc

$NXGL
Financials

Live finance-specific insights

NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially